An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3)
about
An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3)
description
A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov
@en
klinisch onderzoek
@nl
name
An Exploratory Safety and Immu ...... 6 in Women With HSIL; CIN 2/3)
@en
An Exploratory Safety and Immu ...... 6 in Women With HSIL; CIN 2/3)
@nl
type
label
An Exploratory Safety and Immu ...... 6 in Women With HSIL; CIN 2/3)
@en
An Exploratory Safety and Immu ...... 6 in Women With HSIL; CIN 2/3)
@nl
prefLabel
An Exploratory Safety and Immu ...... 6 in Women With HSIL; CIN 2/3)
@en
An Exploratory Safety and Immu ...... 6 in Women With HSIL; CIN 2/3)
@nl
P1050
P3098
NCT02529930